Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|December 5, 2019
Investigating Emotion in Malay, Australian and Iranian Individuals with and without DepressionLaura Jobson, Vida Mirabolfathi, Shiva Moshirpanahi, et al.
Theranostics|August 8, 2018
Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabineManendra Babu Lankadasari, Jayasekharan S Aparna, Sabira Mohammed, et al.
Journal of Cancer Policy|February 22, 2023
Investigating stigma during the COVID-19 pandemic: Living conditions, social determinants and experiences of infection among employees at a tertiary referral cancer centrePriya Ranganathan, Sandeep Tandon, Sufiyan Khan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 1, 2015
Clinical and hematological profile of acute megakaryoblastic leukemia: a 2 year studyA V Jayasudha, Rekha A Nair, Priya Mary Jacob, et al.
Cancer Letters|July 23, 2023
Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1Sergio Corrales-Guerrero, Tiantian Cui, Veronica Castro-Aceituno, et al.
Molecular Therapy Oncolytics|September 7, 2023
JNTX-101, a novel albumin-encapsulated gemcitabine prodrug, is efficacious and operates via caveolin-1-mediated endocytosisTiantian Cui, Sergio Corrales-Guerrero, Veronica Castro-Aceituno, et al.
Plos One|February 19, 2020
Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancerSindhu Nair, Hoa Q Trummell, Rajani Rajbhandari, et al.
Glia|January 31, 2018
MicroRNA-31 is required for astrocyte specificationGordon P Meares, Rajani Rajbhandari, Magda Gerigk, et al.
Nucleic Acids Research|October 2, 2025
KRAS-induced STN1 (OBFC1) promotes proper CTC1-STN1-TEN1 complex-independent DNA double-strand break repair and cell cycle checkpoint maintenance in pancreatic cancerChangxian Shen, Tiantian Cui, Linlin Yang, et al.
Breast Cancer Research and Treatment|April 16, 2021
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly Ann Niravath, Joe Ensor, et al.
Pageof 4